000 03272cam  2200505zi 4500
0019.884270
003CaOODSP
00520221107170823
006m     o  d f      
007cr |||||||||||
008200204t20202020oncd    ob   f000 0 eng d
020 |a9780660339382
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-344/2020E-PDF
1001 |aLeigh-Bennett, Richard, |eauthor.
24510|aAssessment of Health Canada's communications to external stakeholders on marketed health products : |bqualitative research : final report / |csubmitted by: Richard Leigh-Bennett ; prepared for: Health Canada.
24617|aMarketed health products communications research report
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2020.
264 4|c©2020
300 |a1 online resource (42 pages) : |bgraphs + |e1 executive summary (6 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aTitle from cover.
500 |a"February 19, 2020."
500 |aIssued also in HTML format.
500 |a"Supplier name: Pollara Strategic Insights."
500 |a"Contract Number: HT372-184553/001/CY."
500 |a"POR Registration number: 136-18."
500 |a"Health Canada POR Number: 18-25."
500 |aIssued also in French under title: Évaluation des communications de Santé Canada aux intervenants externes à propos des produits de santé commercialisés : recherche qualitative : rapport final.
504 |aIncludes references.
520 |a"Health product safety in Canada is a shared responsibility. Many different organizations and individuals, including Health Canada, health care professionals, manufacturers, consumers and others, have a role to play in the effective and timely communication of health product safety information. As part of its role, Health Canada develops a wide range of products designed to communicate externally to key stakeholders (including the public) on issues related to health product safety, including, but not limited to: guidance documents; risk communications; health product safety information; and, communications around transparency"--Background and objectives, page 8.
650 0|aHealth products|xGovernment policy|zCanada|xPublic opinion.
650 0|aHealth risk communication|xGovernment policy|zCanada|xPublic opinion.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada.
7102 |aPollara Strategic Insights.
77508|tÉvaluation des communications de Santé Canada aux intervenants externes à propos des produits de santé commercialisés : |w(CaOODSP)9.884271
85640|qPDF|s1,021 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H14-344-2020-eng.pdf|zFinal report
85640|qPDF|s487 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H14-344-2020-1-eng.pdf|zExecutive summary
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/136-18-e/mhpd-e.html|zFinal report
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/136-18-e/summary/summary.html|zExecutive summary